{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:44Z","timestamp":1772119544486,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01049-6","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T08:02:51Z","timestamp":1682582571000},"page":"3969-3980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Research in the genetics of pheochromocytoma and paraganglioma: a bibliometric analysis from 2002 to 2022"],"prefix":"10.1007","volume":"23","author":[{"given":"Lei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"issue":"9","key":"1049_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11886-019-1184-y","volume":"21","author":"L Fishbein","year":"2019","unstructured":"Fishbein L. Pheochromocytoma\/paraganglioma: Is this a Genetic Disorder? Curr Cardiol Rep. 2019;21(9):104.","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"1049_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","volume":"62","author":"RM Cawthon","year":"1990","unstructured":"Cawthon RM, Weiss R, Xu GF, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990;62(1):193\u2013201.","journal-title":"Cell"},{"issue":"9","key":"1049_CR3","first-page":"1291","volume":"5","author":"I Ikeda","year":"1990","unstructured":"Ikeda I, Ishizaka Y, Tahira T, et al. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines. Oncogene. 1990;5(9):1291\u20136.","journal-title":"Oncogene"},{"issue":"1","key":"1049_CR4","first-page":"97","volume":"5","author":"T Tahira","year":"1990","unstructured":"Tahira T, Ishizaka Y, Itoh F, Sugimura T, Nagao M. Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene. 1990;5(1):97\u2013102.","journal-title":"Oncogene"},{"issue":"2","key":"1049_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","volume":"11","author":"J Favier","year":"2015","unstructured":"Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015;11(2):101\u201311.","journal-title":"Nat Rev Endocrinol"},{"issue":"20","key":"1049_CR6","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1158\/1078-0432.CCR-16-2250","volume":"23","author":"L Remacha","year":"2017","unstructured":"Remacha L, Comino-Mendez I, Richter S, et al. Targeted exome sequencing of Krebs cycle genes reveals candidate cancer-predisposing mutations in pheochromocytomas and paragangliomas. Clin Cancer Res. 2017;23(20):6315\u201324.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1049_CR7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41436-018-0003-y","volume":"20","author":"L Remacha","year":"2018","unstructured":"Remacha L, Curras-Freixes M, Torres-Ruiz R, et al. Gain-of-function mutations in DNMT3A in patients with paraganglioma. Genet Med. 2018;20(12):1644\u201351.","journal-title":"Genet Med"},{"issue":"8","key":"1049_CR8","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","volume":"78","author":"A Buffet","year":"2018","unstructured":"Buffet A, Morin A, Castro-Vega LJ, et al. Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas. Cancer Res. 2018;78(8):1914\u201322.","journal-title":"Cancer Res"},{"issue":"5","key":"1049_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ajhg.2019.04.010","volume":"104","author":"L Remacha","year":"2019","unstructured":"Remacha L, Pirman D, Mahoney CE, et al. Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas. Am J Hum Genet. 2019;104(5):1008\u201310.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"1049_CR10","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","volume":"22","author":"RA Toledo","year":"2016","unstructured":"Toledo RA, Qin Y, Cheng ZM, et al. Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas. Clin Cancer Res. 2016;22(9):2301\u201310.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1049_CR11","first-page":"1","volume":"2","author":"C Chen","year":"2017","unstructured":"Chen C. Science mapping: a systematic review of the literature. J Data Inf Sci. 2017;2(2):1\u201340.","journal-title":"J Data Inf Sci"},{"key":"1049_CR12","doi-asserted-by":"publisher","first-page":"993921","DOI":"10.3389\/fonc.2022.993921","volume":"12","author":"SL Duan","year":"2022","unstructured":"Duan SL, Qi L, Li MH, Liu LF, Wang Y, Guan X. The top 100 most-cited papers in pheochromocytomas and paragangliomas: A bibliometric study. Front Oncol. 2022;12:993921.","journal-title":"Front Oncol"},{"key":"1049_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF02016840","volume":"1","author":"D Beaver","year":"1978","unstructured":"Beaver D, Rosen R. Studies in scientific collaboration. Scientometrics. 1978;1:65\u201384.","journal-title":"Scientometrics"},{"key":"1049_CR14","unstructured":"Small H. Co-citation in the scientific literature: a new measure of the relationship between two documents."},{"issue":"02","key":"1049_CR15","first-page":"242","volume":"33","author":"Y Chen","year":"2015","unstructured":"Chen Y, Chen C, Liu Z, Zhigang Hu, Wang X. Methodological functions of CiteSpace knowledge graph. Sci Res. 2015;33(02):242\u201353.","journal-title":"Sci Res"},{"key":"1049_CR16","doi-asserted-by":"crossref","unstructured":"Hirsch J. An index to quantify an individual\u2019s scientific research output. Proceedings of the National Academy of Sciences of the United States of America (PNAS). 2005.","DOI":"10.1073\/pnas.0507655102"},{"issue":"6","key":"1049_CR17","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1049_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","volume":"50","author":"L Fishbein","year":"2021","unstructured":"Fishbein L, Del Rivero J, Else T, et al. The North American neuroendocrine tumor society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma. Pancreas. 2021;50(4):469\u201393.","journal-title":"Pancreas"},{"issue":"10","key":"1049_CR19","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","volume":"23","author":"R Garcia-Carbonero","year":"2021","unstructured":"Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, et al. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin Transl Oncol. 2021;23(10):1995\u20132019.","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"1049_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1097\/00005537-200007000-00030","volume":"110","author":"AE Petropoulos","year":"2000","unstructured":"Petropoulos AE, Luetje CM, Camarata PJ, Whittaker CK, Lee G, Baysal BE. Genetic analysis in the diagnosis of familial paragangliomas. Laryngoscope. 2000;110(7):1225\u20139.","journal-title":"Laryngoscope"},{"issue":"19","key":"1049_CR21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HP Neumann","year":"2002","unstructured":"Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459\u201366.","journal-title":"N Engl J Med"},{"issue":"8","key":"1049_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292(8):943\u201351.","journal-title":"JAMA"},{"issue":"9263","key":"1049_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(00)04378-6","volume":"357","author":"D Astuti","year":"2001","unstructured":"Astuti D, Douglas F, Lennard TW, et al. Germline SDHD mutation in familial phaeochromocytoma. Lancet. 2001;357(9263):1181\u20132.","journal-title":"Lancet"},{"issue":"8","key":"1049_CR24","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1210\/jc.2008-2504","volume":"94","author":"N Burnichon","year":"2009","unstructured":"Burnichon N, Rohmer V, Amar L, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab. 2009;94(8):2817.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1049_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181\u201393.","journal-title":"Cancer Cell"},{"key":"1049_CR26","doi-asserted-by":"crossref","unstructured":"Group NGSiPS, Toledo RA, Burnichon N, et al. Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol. 2017;13(4):233\u201347","DOI":"10.1038\/nrendo.2016.185"},{"issue":"2","key":"1049_CR27","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.beem.2020.101416","volume":"34","author":"A Buffet","year":"2020","unstructured":"Buffet A, Burnichon N, Favier J, Gimenez-Roqueplo AP. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101416.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"1049_CR28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91(3):827\u201336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1049_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11864-020-00787-z","volume":"21","author":"M Ilanchezhian","year":"2020","unstructured":"Ilanchezhian M, Jha A, Pacak K, Del Rivero J. Emerging Treatments for Advanced\/Metastatic Pheochromocytoma and Paraganglioma. Curr Treat Options Oncol. 2020;21(11):85.","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"1049_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/jmedgenet-2018-105714","volume":"56","author":"L Ben Aim","year":"2019","unstructured":"Ben Aim L, Pigny P, Castro-Vega LJ, et al. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma. J Med Genet. 2019;56(8):513\u201320.","journal-title":"J Med Genet"},{"issue":"6","key":"1049_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","volume":"55","author":"KA Andrews","year":"2018","unstructured":"Andrews KA, Ascher DB, Pires DEV, et al. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB. SDHC and SDHD J Med Genet. 2018;55(6):384\u201394.","journal-title":"SDHC and SDHD J Med Genet"},{"issue":"2","key":"1049_CR32","doi-asserted-by":"publisher","first-page":"101354","DOI":"10.1016\/j.beem.2019.101354","volume":"34","author":"S Jasim","year":"2020","unstructured":"Jasim S, Jimenez C. Metastatic pheochromocytoma and paraganglioma: management of endocrine manifestations, surgery and ablative procedures, and systemic therapies. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101354.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"14","key":"1049_CR33","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1158\/1078-0432.CCR-19-2335","volume":"26","author":"Y Liu","year":"2020","unstructured":"Liu Y, Pang Y, Zhu B, et al. Therapeutic Targeting of SDHB-mutated pheochromocytoma\/paraganglioma with pharmacologic ascorbic acid. Clin Cancer Res. 2020;26(14):3868\u201380.","journal-title":"Clin Cancer Res"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01049-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01049-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01049-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T16:15:51Z","timestamp":1698768951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01049-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1049"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01049-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2597108\/v1","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"17 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}